Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Temporal Trends and Clinical Characteristics of Incretin-Based Therapy Use in Women With Polycystic Ovary Syndrome: A Real-World Cohort Study From a Polish Private Healthcare Network
Diabetes, obesity & metabolism, 2026
Electrospun Nanofiber Oral Thin Film Platform for Sublingual Peptide Delivery: A Promising Alternative to Conventional Semaglutide Formulations
Diabetes, obesity & metabolism, 2026
The Effect of Semaglutide on Quality of Life in Adults With Overweight or Obesity: A Brief Systematic Review and Meta-Analysis
Diabetes, obesity & metabolism, 2026
Weight Changes With Lower Doses of Semaglutide in Clinical Practice: Findings From the Chinese HARMONY Cohort
Diabetes, obesity & metabolism, 2026
Semaglutide and Risk of Pancreatic Cancer: A Meta-Analysis of Randomised Trials
Diabetes, obesity & metabolism, 2026
SURMOUNT-REAL UK: A Pragmatic Randomized Clinical Trial to Assess the Effectiveness of Tirzepatide in Adults With Obesity
Obesity (Silver Spring, Md.), 2026
Tirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO)
Med (New York, N.Y.), 2026;:101183
Hierarchical regulation and mechanism of “open-hollow-fibrous network” structures: Osteogenic-angiogenic coupling responses of poly(γ-benzyl-L-glutamate) microspheres
Biomaterials advances, 2026;188:215017
Sex, Not Age, Predicts Weight Loss Outcomes With Tirzepatide: A Retrospective Analysis
Obesity (Silver Spring, Md.), 2026
Effectiveness of tirzepatide in Japanese patients with type 2 diabetes but no obesity: A sub-analysis of Hokkaido-TZP study data
Journal of diabetes investigation, 2026
Current trends in semaglutide therapy and strategies to improve its bioavailability
Expert opinion on drug delivery, 2026
Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovation
Med (New York, N.Y.);7(6):101172
Post hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease
Current medical research and opinion, 2026;:1-13
Exercise-induced anaphylaxis with a cofactor of GIP/GLP-1 receptor agonist: A case report
The journal of allergy and clinical immunology. Global, 2026;5(5):100751
Cellulite as a Possible Biomarker of Metabolic Dysfunction: Redefining Body Remodeling in the Glucagon-Like Peptide-1 Era Through the Cellulite Removal Medical Protocol-G21 Concept
Cureus, 2026;18(6):e110805
Reparative Outcomes in Corneal Infection: Linking Adjunctive Tβ4 Treatment to Nerve Regeneration and Visual Function
Investigative ophthalmology & visual science;67(6):22
Drug-induced gastric motility disorders: A disproportionality analysis from the FAERS and CVARD databases
PloS one, 2026;21(6):e0351731
Re: Liu et al.: Rate and risk of nonarteritic anterior ischemic optic neuropathy with semaglutide use for diabetes and weight loss: a systematic review and meta-analysis (Ophthalmology 2026;133;589-598)
Ophthalmology, 2026
Improvement of Refractory Restless Legs Syndrome in a Parkinson’s Disease Patient After Semaglutide Treatment: A Novel Clinical Observation
Journal of movement disorders, 2026
Evidence-informed guidance for the clinical use of oral semaglutide in obesity management
Postgraduate medicine, 2026;:1-11